Theator, the startup that uses AI and computer vision tech to improve surgeons’ performance, today announced an additional $24 million in Series A funding.
It follows an initial $15.5 million Series A round announced in February 2021.
Theator’s surgical intelligence platform uses AI and computer vision to analyze surgical procedures and provide surgeons with actionable insights which improve the quality of surgical care.
It provides video analytics that enable surgeons to review and assess their work from pre-op preparation to post-op analysis, at different angles.
The company was founded in Israel by Dr. Tamir Wolf and Dotan Asselmann in 2018 and is now based in Palo Alto, California.
The extended funding round was again led by Insight Partners with support from existing investors including Blumberg Capital, Mayo Clinic, NFX, StageOne Ventures, iAngels, and former Netflix Chief Product Officer Neil Hunt.
New growth investors include iCON and TripActions’ CEO and Co-founder Ariel Cohen.
Sign up for our free weekly newsletterSubscribe
Theator’s library of surgical video and data contains over 30,000 hours of video, with nearly a billion frames analyzed.
“This funding is a strong vote of confidence in our vision, team, and the field of Surgical Intelligence as the cornerstone of the future of surgery,” said Dr. Tamir Wolf, CEO and Co-founder of Theator.
“Surgical Intelligence is already demonstrating significant improvement in surgical quality and safety.
“It’s thrilling to hear about the impact our partners and collaborators have achieved thus far, and we look forward to this latest investment advancing our mission to transform surgery and alleviate variability and disparity in surgical care worldwide.”
Theator is partnering with leading surgeons, hospitals, professional societies, and research institutions to create a smarter, more transparent operating room.
By making routine video capture and analysis the standard of care in surgery, it derives new insights to help surgeons and hospital systems understand the causes of variability in patient outcomes and reduce it in the future, while also lowering costs and streamlining procedures in the operating room.